DHTKD1 and malignant pleural mesothelioma: In addition, the promoter of the CREBBP/EP300 inhibitory protein 1 (CRI1), a gene specifically expressed in malignant pleural mesothelioma, was used to drive E1a-mediated virotherapy that specifically kills malignant mesothelioma cells but not normal cells [46].